Motilal Oswal Mutual Fund bought 6,26,000 shares of Biocon Limited for ₹25.04 Cr at ₹400.00 apiece in a block deal.
A leading biotechnology company engaged in the manufacture of innovative pharmaceutical products and research services across multiple therapeutic areas. Biocon specializes in biologics, biosimilars, and small molecule drugs, serving patients in oncology, immunology, and diabetes therapeutics globally. The company operates integrated manufacturing facilities and maintains a strong commitment to developing affordable healthcare solutions for patients in emerging markets worldwide.
AMC arm of Motilal Oswal Financial Services, founded on the belief in long-term buy-and-hold quality investing. Manages over Rs 1.5 lakh crore. Famous for the QGLP (Quality, Growth, Longevity, Price) investment framework and concentrated portfolios with very low churn. Flagship Motilal Oswal Midcap and Motilal Oswal Flexi Cap funds reflect deep conviction positioning with 15-25 stock portfolios.
